Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival
Identifieur interne : 003123 ( Pmc/Curation ); précédent : 003122; suivant : 003124Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival
Auteurs : Tristan Gauthier ; Catherine Uzan ; Delphine Lefeuvre ; Aminata Kane ; Geoffroy Canlorbe ; Fredéric Deschamps ; Catherine Lhomme [France] ; Patricia Pautier [France] ; Philippe Morice ; Sébastien GouySource :
- The Oncologist [ 1083-7159 ] ; 2012.
Abstract
This retrospective study describes the incidence, impact on survival, and the risk factors for symptomatic lymphoceles in patients with ovarian cancer.
Url:
DOI: 10.1634/theoncologist.2012-0088
PubMed: 22707515
PubMed Central: 3448413
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003124
Links to Exploration step
PMC:3448413Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival</title><author><name sortKey="Gauthier, Tristan" sort="Gauthier, Tristan" uniqKey="Gauthier T" first="Tristan" last="Gauthier">Tristan Gauthier</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Uzan, Catherine" sort="Uzan, Catherine" uniqKey="Uzan C" first="Catherine" last="Uzan">Catherine Uzan</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Lefeuvre, Delphine" sort="Lefeuvre, Delphine" uniqKey="Lefeuvre D" first="Delphine" last="Lefeuvre">Delphine Lefeuvre</name><affiliation><nlm:aff id="aff2">Biostatistics,</nlm:aff></affiliation></author><author><name sortKey="Kane, Aminata" sort="Kane, Aminata" uniqKey="Kane A" first="Aminata" last="Kane">Aminata Kane</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Canlorbe, Geoffroy" sort="Canlorbe, Geoffroy" uniqKey="Canlorbe G" first="Geoffroy" last="Canlorbe">Geoffroy Canlorbe</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Deschamps, Frederic" sort="Deschamps, Frederic" uniqKey="Deschamps F" first="Fredéric" last="Deschamps">Fredéric Deschamps</name><affiliation><nlm:aff wicri:cut=", and" id="aff3">Radiology</nlm:aff></affiliation></author><author><name sortKey="Lhomme, Catherine" sort="Lhomme, Catherine" uniqKey="Lhomme C" first="Catherine" last="Lhomme">Catherine Lhomme</name><affiliation wicri:level="1"><nlm:aff id="aff4">Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif</wicri:regionArea></affiliation></author><author><name sortKey="Pautier, Patricia" sort="Pautier, Patricia" uniqKey="Pautier P" first="Patricia" last="Pautier">Patricia Pautier</name><affiliation wicri:level="1"><nlm:aff id="aff4">Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif</wicri:regionArea></affiliation></author><author><name sortKey="Morice, Philippe" sort="Morice, Philippe" uniqKey="Morice P" first="Philippe" last="Morice">Philippe Morice</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Gouy, Sebastien" sort="Gouy, Sebastien" uniqKey="Gouy S" first="Sébastien" last="Gouy">Sébastien Gouy</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22707515</idno><idno type="pmc">3448413</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448413</idno><idno type="RBID">PMC:3448413</idno><idno type="doi">10.1634/theoncologist.2012-0088</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">003124</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003124</idno><idno type="wicri:Area/Pmc/Curation">003123</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003123</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival</title><author><name sortKey="Gauthier, Tristan" sort="Gauthier, Tristan" uniqKey="Gauthier T" first="Tristan" last="Gauthier">Tristan Gauthier</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Uzan, Catherine" sort="Uzan, Catherine" uniqKey="Uzan C" first="Catherine" last="Uzan">Catherine Uzan</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Lefeuvre, Delphine" sort="Lefeuvre, Delphine" uniqKey="Lefeuvre D" first="Delphine" last="Lefeuvre">Delphine Lefeuvre</name><affiliation><nlm:aff id="aff2">Biostatistics,</nlm:aff></affiliation></author><author><name sortKey="Kane, Aminata" sort="Kane, Aminata" uniqKey="Kane A" first="Aminata" last="Kane">Aminata Kane</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Canlorbe, Geoffroy" sort="Canlorbe, Geoffroy" uniqKey="Canlorbe G" first="Geoffroy" last="Canlorbe">Geoffroy Canlorbe</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Deschamps, Frederic" sort="Deschamps, Frederic" uniqKey="Deschamps F" first="Fredéric" last="Deschamps">Fredéric Deschamps</name><affiliation><nlm:aff wicri:cut=", and" id="aff3">Radiology</nlm:aff></affiliation></author><author><name sortKey="Lhomme, Catherine" sort="Lhomme, Catherine" uniqKey="Lhomme C" first="Catherine" last="Lhomme">Catherine Lhomme</name><affiliation wicri:level="1"><nlm:aff id="aff4">Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif</wicri:regionArea></affiliation></author><author><name sortKey="Pautier, Patricia" sort="Pautier, Patricia" uniqKey="Pautier P" first="Patricia" last="Pautier">Patricia Pautier</name><affiliation wicri:level="1"><nlm:aff id="aff4">Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif</wicri:regionArea></affiliation></author><author><name sortKey="Morice, Philippe" sort="Morice, Philippe" uniqKey="Morice P" first="Philippe" last="Morice">Philippe Morice</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author><author><name sortKey="Gouy, Sebastien" sort="Gouy, Sebastien" uniqKey="Gouy S" first="Sébastien" last="Gouy">Sébastien Gouy</name><affiliation><nlm:aff id="aff1">Departments of Surgery,</nlm:aff></affiliation></author></analytic><series><title level="j">The Oncologist</title><idno type="ISSN">1083-7159</idno><idno type="eISSN">1549-490X</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>This retrospective study describes the incidence, impact on survival, and the risk factors for symptomatic lymphoceles in patients with ovarian cancer.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Oncologist</journal-id><journal-id journal-id-type="iso-abbrev">Oncologist</journal-id><journal-id journal-id-type="pmc">oncologist</journal-id><journal-id journal-id-type="hwp">theoncologist</journal-id><journal-id journal-id-type="publisher-id">The Oncologist</journal-id><journal-title-group><journal-title>The Oncologist</journal-title></journal-title-group><issn pub-type="ppub">1083-7159</issn><issn pub-type="epub">1549-490X</issn><publisher><publisher-name>AlphaMed Press</publisher-name><publisher-loc>Durham, NC, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22707515</article-id><article-id pub-id-type="pmc">3448413</article-id><article-id pub-id-type="publisher-id">3786427</article-id><article-id pub-id-type="doi">10.1634/theoncologist.2012-0088</article-id><article-categories><subj-group subj-group-type="heading"><subject>Gynecologic Oncology</subject></subj-group></article-categories><title-group><article-title>Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gauthier</surname><given-names>Tristan</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Uzan</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lefeuvre</surname><given-names>Delphine</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kane</surname><given-names>Aminata</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Canlorbe</surname><given-names>Geoffroy</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Deschamps</surname><given-names>Fredéric</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lhomme</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pautier</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Morice</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gouy</surname><given-names>Sébastien</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><sup>a</sup>Departments of Surgery,</aff><aff id="aff2"><sup>b</sup>Biostatistics,</aff><aff id="aff3"><sup>c</sup>Radiology, and</aff><aff id="aff4"><sup>d</sup>Oncology, Institut Gustave Roussy and University Paris-Sud, Villejuif, France</aff></contrib-group><author-notes><corresp>Correspondence: Sébastien Gouy, M.D., Service de Chirurgie, Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France. Telephone:
<phone>33 1 42 11 44 39</phone>; Fax:
<fax>33 1 42 11 52 13</fax>; e-mail: <email>sebastien.gouy@igr.fr</email></corresp><fn fn-type="conflict"><p><bold>Disclosures: Patricia Pautier:</bold> Roche, Ipsen (C/A). The other authors indicated no financial relationships.</p><p>Section Editors: <bold>Dennis Chi</bold>: None; <bold>Peter Harper</bold>: Sanofi, Roche, Imclone, Pfizer, GlaxoSmithKline, Lilly, Genentech (C/A); commercial symposia for Lilly, Novartis, Sanofi, and Roche (H)</p><p>Reviewer “A”: None</p></fn></author-notes><pub-date pub-type="ppub"><month>9</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>15</day><month>6</month><year>2012</year></pub-date><volume>17</volume><issue>9</issue><fpage>1198</fpage><lpage>1203</lpage><history><date date-type="received"><day>29</day><month>2</month><year>2012</year></date><date date-type="accepted"><day>23</day><month>5</month><year>2012</year></date></history><permissions><copyright-statement>©AlphaMed Press</copyright-statement><copyright-year>2012</copyright-year></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="onc00912001198.pdf"></self-uri><abstract abstract-type="precis"><p>This retrospective study describes the incidence, impact on survival, and the risk factors for symptomatic lymphoceles in patients with ovarian cancer.</p></abstract><abstract abstract-type="objectives"><title>Learning Objectives</title><p>After completing this course, the reader will be able to:
<list list-type="order"><list-item><p>Identify risk factors for lymphoceles after cytoreductive surgery in ovarian cancer.</p></list-item><list-item><p>Describe the impact of lymphocleles on outcomes in women with ovarian cancer.</p></list-item></list></p><p>This article is available for continuing medical education credit at <ext-link ext-link-type="uri" xlink:href="http://CME.TheOncologist.com">CME.TheOncologist.com</ext-link></p></abstract><abstract><sec><title>Introduction.</title><p>We describe the incidence, impact on survival, and the risk factors for symptomatic lymphoceles in patients with ovarian cancer.</p></sec><sec><title>Methods.</title><p>This retrospective study includes patients with ovarian cancer who had complete cytoreductive surgery and para-aortic and pelvic lymphadenectomy performed in our institute from 2005 to 2011. Patients were classified into two groups: patients with symptomatic lymphoceles and a control group.</p></sec><sec><title>Results.</title><p>During the study period, 194 patients with epithelial ovarian cancer underwent cytoreductive surgery and a lymphadenectomy without macroscopic residual disease. Fifty-four patients had symptomatic lymphoceles (28%). In the multivariate analysis, only supraradical surgery was significantly and independently associated with the risk of symptomatic lymphoceles occurring postoperatively. Median follow-up was 24.8 months (range, 1–74 months). Survival rates were not significantly different between the symptomatic lymphocele group and the control group. Two-year disease-free survival rates were 54% for the lymphocele group and 48% for the control group. Two-year overall survival rates were 90% for the lymphocele group and 88% for the control group.</p></sec><sec><title>Conclusions.</title><p>Symptomatic lymphoceles occur frequently after cytoreductive surgery in ovarian cancer. Supraradical surgery is an independent risk factor. The occurrence of symptomatic lymphoceles does not decrease survival. Nevertheless, further studies are needed to reduce the risk of lymphoceles in such patients.</p></sec></abstract><kwd-group><kwd>Lymphadenectomy</kwd><kwd>Ovarian cancer</kwd><kwd>Lymphocele</kwd><kwd>Cytoreductive surgery</kwd><kwd>Survival</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003123 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 003123 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:3448413
|texte= Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:22707515" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |